We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Return of gut function was similar between those ...

Tranzyme Pharma Inc.'s drug ulimorelin failed to perform in a trial for bowel resection recovery acceleration, according to top-line results released Monday.

A recent study published in JAMA Surgery demonstrated the cost savings an enhanced recovery program can produce in colon cancer surgery, according to a Pain Medicine News report. The study examined ...

Please provide your email address to receive an email when new articles are posted on . Mechanical bowel preparation and oral antibiotics resulted in fewer overall postoperative complications vs.